Interventional catheterization

Current Opinion in Cardiology

Volumn 15, Issue 4, 2000, Pages 211-215

  Nakanishi, Toshio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANEURYSM; AORTA COARCTATION; ARTIFICIAL EMBOLISM; BALLOON DILATATION; CATHETERIZATION; CORONARY STENT; DEVICE; EVALUATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; IMPLANTATION; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; REVIEW;

AORTIC COARCTATION; BALLOON DILATATION; DUCTUS ARTERIOSUS, PATENT; EMBOLIZATION, THERAPEUTIC; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT, NEWBORN; RADIATION DOSAGE; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0033943445     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200007000-00002     Document Type: Review

References (40)

1. 1 Janorkar S, Goh T, Wilkinson J: Transcatheter closure of patent ductus arteriosus with the use of Rashkind occluders and/or Gianturco coils: long-term follow-up in 123 patients and special reference to comparison, residual shunts, complications, and technique. Am Heart J 1999, 138(6 part 1):1176-1183.
2. 2 Masura J, Walsh KP, Thanopoulous B, et al.: Catheter closure of moderate-to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol 1998, 31:878-882.
3. 3 Sreeram N, Tofeig M, Walsh KP, Hutter P: Lung perfusion studies after detachable coil occlusion of persistent arterial duct. Heart 1999, 81:642-645.
4. 4 Zellers TM, Wylie KD, Moake L: Transcatheter coil occlusion of the small patent ductus arteriosus (<4 mm): improved results with a "multiple coil-no residual shunt" strategy. Cathet Cardiovasc Intervent 2000, 49:307-313.
5. 5 Goyal VS, Fulwani MC, Ramakantan R, et al.: Follow-up after coil closure of patent ductus arteriosus. Am J Cardiol 1999, 83:463-466.
6. 6 Ing FF, Sommer RJ: The snare-assisted technique for transcatheter coil occlusion of moderate to large patent ductus arteriosus: immediate and intermediate results. J Am Coll Cardiol 1999, 33:1710-1718.
7. 7 Johnston TA, Stern HJ, O'Laughlin MP: Transcatheter occlusion of the patent ductus arteriosus: use of the retrievable coil device. Cathet Cardiovasc Intervent 1999, 46:434-437.
8. 8 Grifka MR, Jones TK: Transcatheter closure of large PDA using 0.052′′ Gianturco coils: controlled delivery using a bioptome catheter through a 4 French sheath. Cathet Cardiovasc Intervent 2000, 49:301-306. The authors reported a new procedure for transcatheter vascular occlusion using 0.052-in Gianturco coil, 3 F bioptome, and a long sheath that provides more control of the coil during implant.
9. 9 Patel HT, Cao QL, Rhodes J, Hijazi ZM: Long-term outcome of transcatheter coil closure of small to large patent ductus arteriosus. Cathet Cardiovasc Intervent 1999, 47:457-461. The immediate, short-, and mid-term outcomes of transcatheter coil closure of PDAs using Gianturco coils were reported. A total of 149 patients underwent the procedure without major complications. The median PDA minimal diameter was 2 mm (0.4 to 7 mm). Long-term follow-up of coil closure of PDA indicates that the technique is safe and effective for most patients with PDAs up to a diameter of 7 mm.
10. 10 Ovaert C, Caldarone CA, McCrindle BW, et al.: Endovascular stent implantation for the management of postoperative right ventricular outflow tract obstruction: clinical efficacy. J Thorac Cardiovasc Surg 1999, 118:886-893. This study reviewed the experience with stent implantation in 43 obstructed conduits. Freedom from surgical reintervention was 86% at 1 year, 72% at 2 years, and 47% at 4 years.
11. 11 Hanley FL: Commentary. J Thorac Cardiovasc Surg 2000, 119:506-507. Hanley commented on the surgical and transcatheter management of conduit stenosis.
12. 12 Rao PS: Long-term follow-up results after balloon dilatation of pulmonic stenosis, aortic stenosis, and coarctation of the aorta: a review. Prog Cardiovasc Dis 1999, 42:59-74. The authors evaluated late follow-up results of balloon pulmonary and aortic valvuloplasty and showed low residual gradients and low reintervention-free rates after the procedures.
13. 13 Suarez de Lezo J, Pan M, Romero M, et al.: Immediate and follow-up findings after stent treatment for severe coarctation of aorta. Am J Cardiol 1999, 83:400-406. This study assessed the immediate and follow-up results of stent placement in 48 patients with coarctation of the aorta. Significant relief was always obtained and the isthmus, when hypoplastic, was always expanded with the stent.
14. 14 Magee AG, Brzezinska-Rajszys G, Qureshi SA, et al.: Stent implantation for aortic coarctation and recoarctation. Heart 1999, 82:600-606. This study determined the early results of stent implantation for aortic coarctation or recoarctation. Eighteen stents were implanted during 18 procedures in 17 patients. Immediate results of stent implantation for aortic recoarctation and native coarctation were good.
15. 15 Hakim F, Hawelleh AA, Goussous Y, Hijazi ZM: Simultaneous stent implantation for coarctation of the aorta and closure of patent ductus arteriosus using the Amplatzer duct occluder [see comments]. Cathet Cardiovasc Intervent 1999, 47:36-38.
16. 16 Brzezinska-Rajszys G, Qureshi SA, Ksiazyk J, et al.: Middle aortic syndrome treated by stent implantation [see comments]. Heart 1999, 81:166-170.
17. 17 Rigby ML: The era of transcatheter closure of atrial septal defects [editorial]. Heart 1999, 81:227-228.
18. 18 Wilkinson JL: Can transcatheter closure of atrial septal defect be regarded as a "standard" procedure? [editorial; comment]. Cardiol Young 1999, 9:458-461.
19. 19 Berger F, Ewert P, Bjornstad PG, et al.: Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder. Cardiol Young 1999, 9:468-473. The authors reported their experiences in 200 patients. Mean age was 29.8 years (0.8 to 77.7 years). Transcatheter closure of the ASD proved successful in all without any relevant residual shunts. The occlusion rate after 3 months was 98.1%. A trivial hemodynamically insignificant residual shunt remained in 1.9% of the patients. Closure of central ASDs up to a diameter of 28 mm can be performed with this device.
20. 20 Berger F, Vogel M, Alexi-Meskishvili V, Lange PE: Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999, 118:674-678; discussion 678-680.
21. 21 Fischer G, Kramer HH, Stieh J, et al.: Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal Occluder. Eur Heart J 1999, 20:541-549.
22. 22 Chan KC, Godman MJ, Walsh K, et al,: Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 1999, 82:300-306.
23. 23 Dhitton R, Thanopoulos B, Tsaousis G, et al.: Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart 1999, 82:559-562.
24. 24 Walsh KP, Tofeig M, Kitchiner DJ, et al.: Comparison of the Sideris and Amplatzer septal occlusion devices. Am J Cardiol 1999, 83:933-936.
25. 25 Hoepp HW, Deutsch HJ, La Rosee K, et al.: Transcatheter closure of atrial-septal defects and patent foramen ovale in adults: optimal anatomic adaptation of occlusion device. Am Heart J 1999, 138(5 part 1 ):941 -949.
26. 26 Yasui H, Osada H, Ide H, Fujimura S: Thoracic and cardiovascular surgery in Japan during 1997: annual report by the Japanese Association for Thoracic Surgery. Committee of Science. Jpn J Thorac Cardiovasc Surg 1999, 47:237-251.
27. 27 Visconti KJ, Bichell DP, Jonas RA, et al.: Developmental outcome after surgical versus interventional closure of secundum atrial septal defect in children. Circulation 1999, 100(19 suppl):II145-II150.
28. 28 Ewert P, Berger F, Daehnert I, et al.: Transcatheter closure of atrial septal defects without fluoroscopy: feasibility of a new method. Circulation 2000, 101:847-849.
29. 29 Barceloux DG: Nickel. J Toxicol Clin Toxicol 1999, 37:239-258.
30. 30 Kreutzer J, Ryan CA, Wright JA Jr, et al.: Acute animal studies of the STARFlex system: a new self-centering cardioSEAL septal occluder. Cathet Cardiovasc Intervent 2000, 49:225-233.
31. 31 Hausdorf G, Kaulitz R, Paul T, et al.: Transcatheter closure of atrial septal defect with a new flexible, self-centering device (the STARFlex Occluder). Am J Cardiol 1999, 84:1113-1116.
32. 32 Dall'Agata A, McGhie J, Taams MA, et al.: Secundum atrial septal defect is a dynamic three-dimensional entity [see comments]. Am Heart J 1999, 137:1075-1081.
33. 33 Janorkar S, Goh T, Wilkinson J: Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Cathet Cardiovasc Intervent 1999, 46:43-48.
34. 34 Amin Z, Gu X, Berry JM, et al.: New device for closure of muscular ventricular septal defects in a canine model. Circulation 1999, 100:320-328. This study reported experimental results of closing muscular VSDs with the Amplatz VSD device. Muscular VSDs were created in 10 dogs. The diameter of the defects ranged from 6 to 14 mm. The device was placed with the help of transesophageal echocardiography and fluoroscopy. Placement was successful in all animals. Pathologic examination of the heart revealed complete endothelialization of the device in dogs killed after 3 months.
35. 35 Hijazi ZM, Hakim F, Al-Fadley F, et al.: Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Cathet Cardiovasc Intervent 2000, 49:167-172.
36. 36 Hope SA, Partridge J, Slavik Z: A novel use of an Amplatzer septal occluder. Heart 1999, 81:672-673.
37. 37 Tofeig M, Patel RG, Walsh KP: Transcatheter closure of a mid-muscular ventricular septal defect with an amplatzer VSD occluder device. Heart 1999, 81:438-440.
38. 38 Moore JD, Shim D, Sweet J, et al.: Radiation exposure to children during coit occlusion of the patent ductus arteriosus [see comments]. Cathet Cardiovasc Intervent 1999, 47:449-454.
39. 39 Vitiello R, McCrindle BW, Nykanen D, et al.: Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998, 32:1433-1440.
40. 40 Zeevi B, Berant M, Fogelman R, et al.: Acute complications in the current era of therapeutic cardiac catheterization for congenital heart disease. Cardiol Young 1999, 9:266-272. A review was performed of 425 therapeutic catheter procedures performed at one institution between 1993 and 1997. There were 49 acute complications (11.5%), of which 43 (10.1%) were deemed minor and six (1.4%) were considered major.